4-70335965-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_033122.4(CABS1):c.926C>T(p.Thr309Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000415 in 1,613,538 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_033122.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CABS1 | NM_033122.4 | c.926C>T | p.Thr309Ile | missense_variant | 1/2 | ENST00000273936.6 | NP_149113.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CABS1 | ENST00000273936.6 | c.926C>T | p.Thr309Ile | missense_variant | 1/2 | 1 | NM_033122.4 | ENSP00000273936.4 |
Frequencies
GnomAD3 genomes AF: 0.0000658 AC: 10AN: 151948Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000195 AC: 49AN: 251024Hom.: 0 AF XY: 0.000221 AC XY: 30AN XY: 135664
GnomAD4 exome AF: 0.0000390 AC: 57AN: 1461470Hom.: 0 Cov.: 35 AF XY: 0.0000413 AC XY: 30AN XY: 727038
GnomAD4 genome AF: 0.0000658 AC: 10AN: 152068Hom.: 0 Cov.: 32 AF XY: 0.0000673 AC XY: 5AN XY: 74342
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 18, 2023 | The c.926C>T (p.T309I) alteration is located in exon 1 (coding exon 1) of the CABS1 gene. This alteration results from a C to T substitution at nucleotide position 926, causing the threonine (T) at amino acid position 309 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at